Search Results

The ACCUSYTE™ 3D Fiducial Markers are used to mark the location of a tumor cavity after the tumor has been removed. In addition, the Markers are indicated on situations where soft tissue needs to be marked for future medical procedure such as subsequent Radiation Therapy.

The ACCUSYTE™ 3D Fiducial Marker is an implantable marker comprised of an absorbable suture (polylactic acid) component which absorbs completely in less than one year, and a permanent component, a Platinum or Gold Marker attached to the suture by a crimping operation similar to the operation use to attach the Stainless-Steel Needle. The ACCUSYTE™ 3D Fiducial Marker is provided Sterile for single use and is implantable.

The provided text describes a 510(k) submission for the ACCUSYTE™ 3D Fiducial Marker, aiming to establish substantial equivalence to predicate devices. The study focuses on demonstrating the device's technical characteristics and performance, particularly its visualization compatibility and MRI safety. However, it does not contain the information needed to fully answer all aspects of your request, especially regarding specific acceptance criteria, detailed study designs for those criteria, or the role of AI.

Here's an analysis of the available information:

This document describes a medical device called the ACCUSYTE™ 3D Fiducial Marker. It is a K180027 510(k) Pre-market Notification from 2018 for a Medical Charged-Particle Radiation Therapy System, and thus the description below is limited purely to the device as presented in the document.

1. Table of acceptance criteria and the reported device performance

The document does not explicitly state formal acceptance criteria with specific thresholds for visualization or other performance metrics. Instead, it describes performance data gathered to demonstrate the device's capabilities and substantial equivalence to predicate devices.

• Radiographic Imaging 6-8 weeks after implantation.
• Mammography imaging after 1-year post implantation.

(No specific quantitative clarity metrics or acceptance thresholds are provided, only that it was "clear visualization.") |
| MRI Safety | MR Conditional:

• Static magnetic field of 1.5-Tesla or 3-Tesla.
• Maximum spatial gradient magnetic field of 4,000-gauss/cm (40-T/m).
• Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 2-W/kg in the Normal Operating Mode.
• Expected to produce a maximum temperature rise of ≤2°C after 15-minutes of continuous scanning at 3 Tesla. |
  | MRI Image Artifact | - Image artifact not expected to extend more than 10-mm from the device when imaged with a gradient echo pulse sequence and a 3-Tesla MRI system. |
  | Absorbable Suture Testing| Performed on the Absorbable Suture component (K130735):
• Bacterial Endotoxin (USP Pharmacopeia ) - Pyrogenicity.
• Biocompatibility (ISO-10993) - suture component - Implant.
• Physical Testing - USP 30

Ask a specific question about this device